Solopharm

Solopharm (Grotex OOO) – Russian pharmaceutical company, which produces liquid sterile dosage forms according to GMP standards (license № 00023-LS).[1] Product line consists of infusion and injection solutions, ophthalmic, otolaryngological, gastroenterological, rheumatological and cosmetological products.

History

Solopharm company was established in 2010.[2] The owner and director of Solopharm company is Russian businessman Oleg Zherebtsov. In August 2014 – launch of injection and infusion solution lines by the innovative technology Blow-Fill-Seal accepted in the world as the most perfect technology for production of sterile solutions with opportunity to use aseptic filling or finish sterilization.[3] Solopharm company continues building and assembling new lines to increase the amount of liquid medicines in ophthalmology, otolaryngology, gastroenterology, rheumatology and cosmetology.[4]

Activity

The company activity is directed to development and production of:

Product Lines

References

  1. "Фармзавод Solopharm инвестирует 32 млн евро в строительство третьей очереди". Фармацевтический вестник. 2015-09-22. Archived from the original on 2016-04-18. Retrieved 2016-04-18.
  2. Елена Кром, Наталья Доброва (2015-05-15). "О.Жеребцов: от продуктового ретейла до производства вакцин". РБК. Archived from the original on 2016-04-16. Retrieved 2016-04-16.
  3. Богдан Боколейко (2015-10-05). "Первая конференция компании Solopharm для СМИ. Репортаж канала Санкт-Петербург". Бизнес Петербург. Archived from the original on 2016-04-18. Retrieved 2016-04-18.
  4. "Два инвестиционных проекта получили статус стратегических". Новотека. 2016-01-11. Archived from the original on 2016-04-18. Retrieved 2016-04-18.

External links

This article is issued from Wikipedia - version of the Wednesday, April 20, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.